U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280494) titled 'To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT' on Dec. 01.
Brief Summary: To observe the efficacy and safety of CD7-targeted chimeric antigen receptor T cells in the treatment of T-lymphoblastic leukaemia/lymphoma with postive measurable residual disease positive post allogeneic stem cell transplantation
Study Start Date: Aug. 18
Study Type: INTERVENTIONAL
Condition:
CD7+ T-ALL/LBL
Intervention:
DRUG: CAR-T Therapy
autologous or donor-derived CD7-targeted CAR-T cells, single injection
Recruitment Status: RECRUITING
Sponsor: Peking University People's Hospital
Informatio...